AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)
Historic Construction in Progress for AbCellera Biologics (ABCL) over the last 3 years, with Q3 2025 value amounting to $118.7 million.
- AbCellera Biologics' Construction in Progress rose 2763.44% to $118.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year increase of 2763.44%. This contributed to the annual value of $103.2 million for FY2024, which is 1340.66% up from last year.
- As of Q3 2025, AbCellera Biologics' Construction in Progress stood at $118.7 million, which was up 2763.44% from $116.0 million recorded in Q2 2025.
- In the past 5 years, AbCellera Biologics' Construction in Progress registered a high of $118.7 million during Q3 2025, and its lowest value of $10.5 million during Q2 2023.
- Its 3-year average for Construction in Progress is $68.2 million, with a median of $92.0 million in 2023.
- In the last 5 years, AbCellera Biologics' Construction in Progress skyrocketed by 1340.66% in 2024 and then soared by 79230.77% in 2025.
- Quarter analysis of 3 years shows AbCellera Biologics' Construction in Progress stood at $91.0 million in 2023, then increased by 13.41% to $103.2 million in 2024, then grew by 15.02% to $118.7 million in 2025.
- Its Construction in Progress was $118.7 million in Q3 2025, compared to $116.0 million in Q2 2025 and $108.6 million in Q1 2025.